FDA approves Astellas drug for leaky bladder

WASHINGTON (Reuters) – U.S. drugs regulators gave the nod to Astellas Pharma Inc‘s pill for overactive bladder on Thursday, boosting the Japanese drugmaker’s foothold in the market for the condition.

The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.

(Reporting by Anna Yukhananov; Editing by Gerald E. McCormick)

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes